Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccine-based clinical trials in ovarian cancer.
Leffers N, Daemen T, Boezen HM, Melief KJ, Nijman HW. Leffers N, et al. Expert Rev Vaccines. 2011 Jun;10(6):775-84. doi: 10.1586/erv.11.42. Expert Rev Vaccines. 2011. PMID: 21692699 Review.
Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial.
Leffers N, Lambeck AJ, Gooden MJ, Hoogeboom BN, Wolf R, Hamming IE, Hepkema BG, Willemse PH, Molmans BH, Hollema H, Drijfhout JW, Sluiter WJ, Valentijn AR, Fathers LM, Oostendorp J, van der Zee AG, Melief CJ, van der Burg SH, Daemen T, Nijman HW. Leffers N, et al. Int J Cancer. 2009 Nov 1;125(9):2104-13. doi: 10.1002/ijc.24597. Int J Cancer. 2009. PMID: 19621448 Free article. Clinical Trial.
Antigen-specific active immunotherapy for ovarian cancer.
Leffers N, Daemen T, Helfrich W, Boezen HM, Cohlen BJ, Melief K, Nijman HW. Leffers N, et al. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007287. doi: 10.1002/14651858.CD007287.pub2. Cochrane Database Syst Rev. 2010. PMID: 20091627 Updated. Review.
Potential target antigens for a universal vaccine in epithelial ovarian cancer.
Vermeij R, Daemen T, de Bock GH, de Graeff P, Leffers N, Lambeck A, ten Hoor KA, Hollema H, van der Zee AG, Nijman HW. Vermeij R, et al. Among authors: leffers n. Clin Dev Immunol. 2010;2010:891505. doi: 10.1155/2010/891505. Epub 2010 Sep 15. Clin Dev Immunol. 2010. PMID: 20885926 Free PMC article.
Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: a single-arm phase II study.
Vermeij R, Leffers N, Hoogeboom BN, Hamming IL, Wolf R, Reyners AK, Molmans BH, Hollema H, Bart J, Drijfhout JW, Oostendorp J, van der Zee AG, Melief CJ, van der Burg SH, Daemen T, Nijman HW. Vermeij R, et al. Among authors: leffers n. Int J Cancer. 2012 Sep 1;131(5):E670-80. doi: 10.1002/ijc.27388. Epub 2012 Jan 31. Int J Cancer. 2012. PMID: 22139992 Free article. Clinical Trial.
Antigen-specific active immunotherapy for ovarian cancer.
Leffers N, Daemen T, Helfrich W, Boezen HM, Cohlen BJ, Melief CJ, Nijman HW. Leffers N, et al. Cochrane Database Syst Rev. 2014 Sep 17;(9):CD007287. doi: 10.1002/14651858.CD007287.pub3. Cochrane Database Syst Rev. 2014. PMID: 25229990 Updated. Review.
28 results